Abintus Bio, INC
San Diego, CA
Abintus Bio is developing cutting-edge in vivo CAR therapies that allow for powerful CAR T cells to be generated directly in a patient’s body, eliminating the need for time-consuming and costly collection, engineering and re-infusion of patient T cells. The innovative Abintus approach aims to reprogram T cells inside the body to attack and eliminate tumors.
Program Name(s)Therapy Acceleration Program
Project TitleSupporting in vivo CAR development for blood cancers